Syndax Pharmaceuticals Holds 2026 Annual Shareholder Meeting Amid Strong Oncology Pipeline and Recent Financial Growth
On June 10, 2026, Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) convened its annual meeting of stockholders through a recor...
Read story →